Results 21 to 30 of about 2,770 (170)
Yttrium-90 Microsphere Radioembolization for Treatment of Lung Cancer Hepatic Metastases
Case Reports in Oncology, 2012 Because stage 4 lung cancer is associated with dismal 5-year survival rates, new treatment approaches targeting extrapulmonary disease are necessary. Yttrium-90 microsphere radioembolization is an emerging treatment for metastatic hepatic malignancies ...
Ron C. Gaba, Janesh Lakhoo
doaj +1 more source
Lung Shunt Reduction for Yttrium-90 Radioembolization: Chemoembolization Versus Radioembolization. [PDF]
In Vivo, 2021 To evaluate the efficacy of chemoembolization versus radioembolization in reducing lung shunt fraction (LSF) in patients with hepatocellular carcinoma (HCC).In this retrospective study, from March 2012 to January 2021, 457 patients with HCC underwent planning angiography and 99mTc-macroaggregated albumin imaging for possible yttrium-90 ...
Kim HC +5 more
europepmc +4 more sources
Gastrectomy for the treatment of refractory gastric ulceration after radioembolization with Y microspheres [PDF]
Clinical and Molecular Hepatology, 2014 Transcatheter arterial radioembolization (TARE) with Yttrium-90 (90Y)-labeled microspheres has an emerging role in treatment of patients with unresectable hepatocellular carcinoma.
Sun Young Yim +10 more
doaj +1 more source
Radioembolization for the treatment of hepatocellular carcinoma [PDF]
Clinical and Molecular Hepatology, 2017 Transarterial radioembolization (TARE) with yttrium 90 (90Y), an intra-arterial procedure performed by interventional radiologists, has begun being utilized in managing hepatocellular carcinoma (HCC) in Korea. There are two available TARE products: glass
Hyo-Cheol Kim
doaj +1 more source
Yttrium-90 Microsphere Radioembolization for Hepatocellular Carcinoma
Liver Cancer, 2014 Yttrium-90 (Y90) radioembolization is an emerging strategy to treat liver malignancies, and clinical data supporting its use have accumulated in recent years. Y90-radioembolization has shown clinical effectiveness in intermediate and advanced hepatocellular carcinoma, with a favorable safety profile.
Edeline, Julien +4 more
openaire +3 more sources
Yttrium-90 Radioembolization Therapy for Combined Hepatocellular and Cholangiocarcinoma [PDF]
Gastrointestinal Tumors, 2020 <b><i>Purpose:</i></b> To report outcomes of transarterial radioembolization (TARE) using glass microspheres for the treatment of mixed hepatocellular-cholangiocarcinoma (HCC-CC) in a propensity-matched study. <b><i>Material and Methods:</i></b> Between 2013 and 2019, 10 consecutive patients with ...
Wali, Badar +6 more
openaire +2 more sources
Liver Radioembolization: a New Chapter in Russian Oncology
Российский журнал гастроэнтерологии, гепатологии, колопроктологии, 2019 Recent years have seen an increase in the number of patients with malignant tumours of the liver. In this context, new treatment methods are being actively introduced into practice, one of which is liver radioembolization utilizing microspheres embedded ...
A. D. Kaprin +12 more
doaj +1 more source
Radiology Case Reports, 2021 We report a case of a 26-year-old male who was diagnosed with metastatic desmoplastic small round cell tumor initially treated with systemic chemotherapy followed by tumor debulking and hyperthermic intra-peritoneal chemotherapy.
Harkanwar Gill, MD +3 more
doaj +1 more source
Journal of Interventional Medicine, 2019 Radiation segmentectomy (RS) is a new approach to 90Y radioembolization that has been designed to increase the safety and efficacy of radioembolization in patients with unresectable hepatic malignancies.
Zhongzhi Jia +3 more
doaj +1 more source
Predictive SIRT dosimetry based on a territorial model
EJNMMI Physics, 2017 Background In the planning of selective internal radiation therapy (SIRT) for liver cancer treatment, one major aspect is to determine the prescribed activity and to estimate the resulting absorbed dose inside normal liver and tumor tissue.
Nadine Spahr +4 more
doaj +1 more source